Bacterial disease: Preventing newborn infection with maternal immunization

Science Translational Medicine

Volumn 5, Issue 195, 2013, Pages

  Black, Steven ^a   Margarit, Immaculada ^b   Rappuoli, Rino ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; GROUP B STREPTOCOCCAL DIPHTHERIA TOXOID CRM197 VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

BACTERIAL MENINGITIS; BACTERIAL TRANSMISSION; BREAST MILK; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GROUP B STREPTOCOCCAL INFECTION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY; NEWBORN SEPSIS; NONHUMAN; PASSIVE IMMUNIZATION; PERINATAL INFECTION; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; FEMALE; IMMUNOLOGY; ITALY; PREGNANCY; PREVENTION AND CONTROL; PROCEDURES; STREPTOCOCCAL INFECTIONS; VACCINATION; VERTICAL TRANSMISSION; ARTICLE; METHODOLOGY; STREPTOCOCCUS INFECTION;

FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; ITALY; PREGNANCY; STREPTOCOCCAL INFECTIONS; VACCINATION;

EID: 84883018039     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005451     Document Type: Review

References (37)

1. A. Schuchat, K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, B. A. Perkins, Active Surveillance Team, Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337, 970-976 (1997).
2. A. Schuchat, Group B streptococcus. Lancet 353, 51-56 (1999).
3. C. G. Whitney, M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, A. Schuchat, Active Bacterial Core Surveillance of the Emerging Infections Program Network, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348, 1737-1746 (2003).
4. M. C. Thigpen, C. G. Whitney, N. E. Messonnier, E. R. Zell, R. Lynfield, J. L. Hadler, L. H. Harrison, M. M. Farley, A. Reingold, N. M. Bennett, A. S. Craig, W. Schaff ner, A. Thomas, M. M. Lewis, E. Scallan, A. Schuchat, Emerging Infections Programs Network, Bacterial meningitis in the United States, 1998-2007. N. Engl. J. Med. 364, 2016-2025 (2011).
5. M. M. Giuliani, J. Adu-Bobie, M. Comanducci, B. Aricò, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, B. Capecchi, E. Cartocci, L. Ciucchi, F. Di Marcello, F. Ferlicca, B. Galli, E. Luzzi, V. Masignani, D. Serruto, D. Veggi, M. Contorni, M. Morandi, A. Bartalesi, V. Cinotti, D. Mannucci, F. Titta, E. Ovidi, J. A. Welsch, D. Granoff, R. Rappuoli, M. Pizza, A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U.S.A. 103, 10834-10839 (2006).
6. G. H. McCracken Jr., Group B streptococci: The new challenge in neonatal infections. J. Pediatr. 82, 703-706 (1973).
7. A. Schuchat, Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin. Microbiol. Rev. 11, 497-513 (1998).
8. B. J. Stoll, N. I. Hansen, P. J. Sánchez, R. G. Faix, B. B. Poindexter, K. P. Van Meurs, M. J. Bizzarro, R. N. Goldberg, I. D. Frantz 3rd, E. C. Hale, S. Shankaran, K. Kennedy, W. A. Carlo, K. L. Watterberg, E. F. Bell, M. C. Walsh, K. Schibler, A. R. Laptook, A. L. Shane, S. J. Schrag, A. Das, R. D. Higgins, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics 127, 817-826 (2011).
9. E. J. Weston, T. Pondo, M. M. Lewis, P. Martell-Cleary, C. Morin, B. Jewell, P. Daily, M. Apostol, S. Petit, M. Farley, R. Lynfield, A. Reingold, N. I. Hansen, B. J. Stoll, A. J. Shane, E. Zell, S. J. Schrag, The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr. Infect. Dis. J. 30, 937-941 (2011).
10. R. C. Lancefield, E. H. Freimer, Type-specific polysaccharide antigens of group B streptococci. J. Hyg. (Lond.) 64, 191-203 (1966).
11. C. J. Baker, D. L. Kasper, Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294, 753-756 (1976).
12. C. J. Baker, F. F. Barrett, Transmission of group B streptococci among parturient women and their neonates. J. Pediatr. 83, 919-925 (1973).
13. M. R. Law, G. Palomaki, Z. Alfirevic, R. Gilbert, P. Heath, C. McCartney, T. Reid, S. Schrag, The prevention of neonatal group B streptococcal disease: A report by a working group of the Medical Screening Society. J. Med. Screen. 12, 60-68 (2005).
14. F. Y. Lin, L. E. Weisman, J. Troendle, K. Adams, Prematurity is the major risk factor for late-onset group B streptococcus disease. J. Infect. Dis. 188, 267-271 (2003).
15. J. R. Verani, S. J. Schrag, Group B streptococcal disease in infants: Progress in prevention and continued challenges. Clin. Perinatol. 37, 375-392 (2010).
16. C. R. Phares, R. Lynfield, M. M. Farley, J. Mohle-Boetani, L. H. Harrison, S. Petit, A. S. Craig, W. Schaff ner, S. M. Zansky, K. Gershman, K. R. Stefonek, B. A. Albanese, E. R. Zell, A. Schuchat, S. J. Schrag, Active Bacterial Core Surveillance/Emerging Infections Program Network, Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. J. Am. Med. Assoc. 299, 2056-2065 (2008).
17. P. T. Heath, G. Balfour, A. M. Weisner, A. Efstratiou, T. L. Lamagni, H. Tighe, L. A. O'Connell, M. Caff erkey, N. Q. Verlander, A. Nicoll, A. C. McCartney, PHLS Group B Streptococcus Working Group, Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363, 292-294 (2004).
18. C. Poyart, H. Réglier-Poupet, A. Tazi, A. Billoët, N. Dmytruk, P. Bidet, E. Bingen, J. Raymond, P. Trieu-Cuot, Invasive group B streptococcal infections in infants, France. Emerg. Infect. Dis. 14, 1647-1649 (2008).
19. R. Libster, K. M. Edwards, F. Levent, M. S. Edwards, M. A. Rench, L. A. Castagnini, T. Cooper, R. C. Sparks, C. J. Baker, P. E. Shah, Long-term outcomes of group B streptococcal meningitis. Pediatrics 130, e8-e15 (2012).
20. C. Whidbey, M. I. Harrell, K. Burnside, L. Ngo, A. K. Becraft, L. M. Iyer, L. Aravind, J. Hitti, K. M. Adams Waldorf, L. Rajagopal, A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J. Exp. Med. 210, 1265-1281 (2013).
21. K. M. Edmond, C. Kortsalioudaki, S. Scott, S. J. Schrag, A. K. Zaidi, S. Cousens, P. T. Heath, Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet 379, 547-556 (2012).
22. A. F. Dagnew, M. C. Cunnington, Q. Dube, M. S. Edwards, N. French, R. S. Heyderman, S. A. Madhi, K. Slobod, S. A. Clemens, Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin. Infect. Dis. 55, 91-102 (2012).
23. H. C. Dillon Jr., E. Gray, M. A. Pass, B. M. Gray, Anorectal and vaginal carriage of group B streptococci during pregnancy. J. Infect. Dis. 145, 794-799 (1982).
24. H. T. Jordan, M. M. Farley, A. Craig, J. Mohle-Boetani, L. H. Harrison, S. Petit, R. Lynfield, A. Thomas, S. Zansky, K. Gershman, B. A. Albanese, W. Schaff ner, S. J. Schrag, Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC, Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: A multistate, population-based analysis. Pediatr. Infect. Dis. J. 27, 1057-1064 (2008).
25. H. Bedford, J. de Louvois, S. Halket, C. Peckham, R. Hurley, D. Harvey, Meningitis in infancy in England and Wales: Follow up at age 5 years. BMJ 323, 533-536 (2001).
26. C. L. Cutland, S. A. Madhi, E. R. Zell, L. Kuwanda, M. Laque, M. Groome, R. Gorwitz, M. C. Thigpen, R. Patel, S. C. Velaphi, P. Adrian, K. Klugman, A. Schuchat, S. J. Schrag, PoPS Trial Team, Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: A randomised, controlled trial. Lancet 374, 1909-1916 (2009).
27. C. J. Baker, D. L. Kasper, A. Paredes, S. Alpert, W. M. McCormack, D. Goroff, Tager IRAB, Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J. Clin. Invest. 59, 810-818 (1977).
28. C. J. Baker, M. A. Rench, M. S. Edwards, R. J. Carpenter, B. M. Hays, D. L. Kasper, Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N. Engl. J. Med. 319, 1180-1185 (1988).
29. C. J. Baker, M. A. Rench, M. Fernandez, L. C. Paoletti, D. L. Kasper, M. S. Edwards, Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J. Infect. Dis. 188, 66-73 (2003).
30. D. L. Kasper, L. C. Paoletti, M. R. Wessels, H. K. Guttormsen, V. J. Carey, H. J. Jennings, C. J. Baker, Immune response to type III group B streptococcal polysaccharidetetanus toxoid conjugate vaccine. J. Clin. Invest. 98, 2308-2314 (1996).
31. P. T. Heath, An update on vaccination against group B streptococcus. Expert Rev. Vaccines 10, 685-694 (2011).
32. D. Maione, I. Margarit, C. D. Rinaudo, V. Masignani, M. Mora, M. Scarselli, H. Tettelin, C. Brettoni, E. T. Iacobini, R. Rosini, N. D'Agostino, L. Miorin, S. Buccato, M. Mariani, G. Galli, R. Nogarotto, V. Nardi-Dei, F. Vegni, C. Fraser, G. Mancuso, G. Teti, L. C. Madoff, L. C. Paoletti, R. Rappuoli, D. L. Kasper, J. L. Telford, G. Grandi, Identification of a universal Group B Streptococcus vaccine by multiple genome screen. Science 309, 148-150 (2005).
33. I. Margarit, C. D. Rinaudo, C. L. Galeotti, D. Maione, C. Ghezzo, E. Buttazzoni, R. Rosini, Y. Runci, M. Mora, S. Buccato, M. Pagani, E. Tresoldi, A. Berardi, R. Creti, C. J. Baker, J. L. Telford, G. Grandi, Preventing bacterial infections with pilus-based vaccines: The group B streptococcus paradigm. J. Infect. Dis. 199, 108-115 (2009).
34. J. A. Englund, I. N. Mbawuike, H. Hammill, M. C. Holleman, B. D. Baxter, W. P. Glezen, Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J. Infect. Dis. 168, 647-656 (1993).
35. K. Zaman, E. Roy, S. E. Arifeen, M. Rahman, R. Raqib, E. Wilson, S. B. Omer, N. S. Shahid, R. F. Breiman, M. C. Steinhoff, Eff ectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med. 359, 1555-1564 (2008).
36. R. Andrews, P.T. Heath, Communications during Merieux Meeting on Maternal Immunization, Annecy, 24 to 26 September, 2012.
37. M. K. Van Dyke, C. R. Phares, R. Lynfield, A. R. Thomas, K. E. Arnold, A. S. Craig, J. Mohle-Boetani, K. Gershman, W. Schaff ner, S. Petit, S. M. Zansky, C. A. Morin, N. L. Spina, K. Wymore, L. H. Harrison, K. A. Shutt, J. Bareta, S. N. Bulens, E. R. Zell, A. Schuchat, S. J. Schrag, Evaluation of universal antenatal screening for group B streptococcus. N. Engl. J. Med. 360, 2626-2636 (2009).